Skip to Main Content
Table 2

Univariate analysis for OS and PFS for all patients in the cohort

OS
PFS
Prognostic factors at transplantationRR (95% confidence interval)PRR (95% confidence interval)P
ALC-15 ≥ 0.5 × 109 lymphocyte/kg 0.459 (0.267-0.710) 0.0002 0.527 (0.355-0.741) 0.0001 
β-2 Microglobulin ≥ 2.7 mg/L 1.482 (1.039-2.085) 0.031 1.475 (1.093-1.967) 0.012 
Circulating plasma cells >1% 2.601 (1.255-4.501) 0.014 2.491 (1.351-4.000) 0.006 
Conditioning regimen: melphalan/total body irradiation versus melphalan alone 0.638 (0.407-1.106) 0.102 0.716 (0.494-1.119) 0.132 
C-reactive protein ≥ 0.8 mg/L 1.375 (0.870-2.030) 0.160   
Creatinine > 2.0 mg/L   1.475 (0.910-2.177) 0.107 
Interventricular septal thickness ≥ 15 mm 1.523 (1.069-2.141) 0.021 1.424 (1.045-1.908) 0.026 
LDH > normal 1.477 (0.933-2.183) 0.091 1.526 (1.045-2.127) 0.030 
No. organs involved > 2 1.876 (1.289-2.671) 0.0015 1.796 (1.300-2.429) 0.0007 
No. prior therapies to ASCT ≥ 1   1.316 (0.984-1.743) 0.06 
Stem cell mobilization regimen:     
G-CSF versus Cytoxan/GM-CSF 0.666 (0.456-1.002) 0.051 0.766 (0.570-1.054) 0.100 
Troponin T ≥ 0.035* 2.278 (1.413-3.593) 0.0012 2.177 (1.492-3.111) 0.0001 
Urine M protein > 0.25 g/d 1.319 (0.907-1.919) 0.146 1.412 (1.066-1.876) 0.016 
OS
PFS
Prognostic factors at transplantationRR (95% confidence interval)PRR (95% confidence interval)P
ALC-15 ≥ 0.5 × 109 lymphocyte/kg 0.459 (0.267-0.710) 0.0002 0.527 (0.355-0.741) 0.0001 
β-2 Microglobulin ≥ 2.7 mg/L 1.482 (1.039-2.085) 0.031 1.475 (1.093-1.967) 0.012 
Circulating plasma cells >1% 2.601 (1.255-4.501) 0.014 2.491 (1.351-4.000) 0.006 
Conditioning regimen: melphalan/total body irradiation versus melphalan alone 0.638 (0.407-1.106) 0.102 0.716 (0.494-1.119) 0.132 
C-reactive protein ≥ 0.8 mg/L 1.375 (0.870-2.030) 0.160   
Creatinine > 2.0 mg/L   1.475 (0.910-2.177) 0.107 
Interventricular septal thickness ≥ 15 mm 1.523 (1.069-2.141) 0.021 1.424 (1.045-1.908) 0.026 
LDH > normal 1.477 (0.933-2.183) 0.091 1.526 (1.045-2.127) 0.030 
No. organs involved > 2 1.876 (1.289-2.671) 0.0015 1.796 (1.300-2.429) 0.0007 
No. prior therapies to ASCT ≥ 1   1.316 (0.984-1.743) 0.06 
Stem cell mobilization regimen:     
G-CSF versus Cytoxan/GM-CSF 0.666 (0.456-1.002) 0.051 0.766 (0.570-1.054) 0.100 
Troponin T ≥ 0.035* 2.278 (1.413-3.593) 0.0012 2.177 (1.492-3.111) 0.0001 
Urine M protein > 0.25 g/d 1.319 (0.907-1.919) 0.146 1.412 (1.066-1.876) 0.016 
*

Only available data in 102 patients.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept